Teresa Brevetti currently serves as the Senior Director at Bausch + Lomb, where she leverages her extensive expertise in ophthalmology, particularly in the specialized field of glaucoma, to drive innovative medical affairs initiatives. With a robust background in both corporate and clinical environments, Teresa has...
Teresa Brevetti currently serves as the Senior Director at Bausch + Lomb, where she leverages her extensive expertise in ophthalmology, particularly in the specialized field of glaucoma, to drive innovative medical affairs initiatives. With a robust background in both corporate and clinical environments, Teresa has established herself as a pivotal figure in the pharmaceutical industry, known for her strategic planning and execution of medical product support. Her role encompasses overseeing key projects that enhance the understanding and treatment of glaucoma, ensuring that Bausch + Lomb remains at the forefront of ophthalmic innovation.
In her capacity as Senior Director, Teresa is instrumental in fostering relationships with key opinion leaders (KOLs) and guiding investigator-initiated research that aligns with the company’s mission to improve patient outcomes. Her reputation for delivering excellent results is underscored by her adeptness in mentoring and coaching teams, cultivating a culture of continuous learning and development within the organization. Teresa’s strategic insights not only enhance team training but also contribute to the successful launch and support of new ophthalmic therapies.
Her comprehensive credentials and experience in medical affairs enable her to navigate complex regulatory landscapes and align clinical research with market needs effectively. As a resourceful leader, Teresa is committed to advancing the field of ophthalmology, particularly in glaucoma management, and her contributions at Bausch + Lomb are pivotal in shaping the future of eye care. Through her dedication and expertise, she continues to make a significant impact on both the company and the broader medical community.